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https://Minimally invasive treatment of vascular complications
after neoaortoiliac system reconstruction using
autologous vein graftsJeroen J. W. M. Brouwers, MD,a Tarik R. Baetens, MD,b and Jan van Schaik, MD,a Leiden, The NetherlandsABSTRACT
Treatment of complications after neoaortoiliac system vein reconstruction is a complex clinical problem with poor
results. Endovascular treatment might offer an acceptable outcome in selected cases. We report two rare complications
after neoaortoiliac system vein reconstruction for an infected aortic graft. These complications were treated with
minimally invasive endovascular techniques. A 54-year-oldman presented with an arterioureteral ﬁstula located between
the right ureter and the right branch of the venous reconstruction. The second case describes a 71-year-old man
who developed a large dilation proximally in the venous reconstruction. (J Vasc Surg Cases and Innovative Techniques
2018;4:283-6.)
Keywords: Endovascular procedures; Prosthesis-related infections/surgery; Aorta; Abdominal/surgeryNeoaortoiliac system (NAIS) reconstruction using the
femoral vein is one of the treatment options in aortic
prosthetic graft infection; it was ﬁrst described in 1993
by Clagett et al1 and Nevelsteen et al.2 NAIS vein recon-
struction is an accepted procedure that provides good
results with a primary patency rate of 81% and a second-
ary or assisted primary patency rate of 91% at 6 years.3
The perioperative (30-day) mortality rate is #10%, with
a 30% to 50% mortality rate at 5 years.4
Treatment of complications after NAIS vein reconstruc-
tion is a complex problem. A laparotomy and vascular
reconstruction or local débridement is often needed,
with poor results.3,5-7 Minimally invasive endovascular
treatment could be a good option in selected cases
and might beneﬁt outcome. Both patients consented
to publication of this report.
CASE REPORTS
Case 1. A 54-year-old man had undergone an aortobifemoral
graft interposition in Spain for ruptured infrarenal aortic aneu-
rysm in 2011. Two months after the initial surgery, he presented
at our hospital with complaints of progressive malaise and pain
in his left ﬂank. Based on his laboratory results (C-reactive pro-
tein level, 304 mg/L; leukocyte count, 11  109/L; and erythrocyte
sedimentation rate, >140 mm/h) and computed tomographyhe Department of Vascular Surgerya and Department of Radiology,b
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doi.org/10.1016/j.jvscit.2018.08.013angiography (CTA) scan, an infected graft was diagnosed. An
autogenous vein reconstruction was performed by in situ
replacement of the aortobifemoral graft by a neobifurcation
using both femoral veins. During this operation, a connection
between the colon and the aortic graft was diagnosed as a
probable cause of the graft infection; the defect was primarily
closed. Furthermore, an iatrogenic ureteral injury occurred (no
preoperative ureteral stents were placed) and was corrected by
end-to-end anastomosis over a double J catheter. Antibiotics
were given for 6 weeks postoperatively. This antibiotic regimen
consisted of cefuroxime, metronidazole, vancomycin, and cas-
pofungin based on cultures. Six weeks after the operation, the
double J catheter was removed. Seven weeks after reconstruc-
tion, the patient presented with severe anemia caused by
excessive hematuria. On examination of the abdominal CTA
scan, there was a high suspicion of a ﬁstula between the right
ureter and the right leg of the venous bypass (Fig 1). An endo-
vascular repair using an aortouni-iliac device (Endurant, Med-
tronic, Minneapolis, Minn) was performed on the right side
(Fig 2). The left external iliac artery was ligated, and left leg
circulation was restored by performing an 8-mm Dacron
femorofemoral crossover bypass (Vascutek Ltd, Renfrewshire,
Scotland). Perioperatively, the same antibiotics were restarted
(cefuroxime, metronidazole, vancomycin, and caspofungin) for
up to 1 week postoperatively. During follow-up, after 3 years, he
developed a type B aortic dissection that was treated conser-
vatively. Several months later, he developed a type A aortic
dissection, for which he underwent a Bentall procedure. Up to
now, follow-up by Doppler echocardiography and CTA scanning
remains uneventful.
Case 2. A 71-year-old man with a history of hypertension and
atrial ﬁbrillation underwent an aortobifemoral graft for aneu-
rysmal disease of the abdominal aorta and iliac arteries in 2008.
Four years later, the aortobifemoral graft was replaced by in situ
autogenous vein reconstruction using both femoral veins
because of graft infection (Fig 3). During follow-up, a progressive
dilation located directly above the bifurcation in the venous283
Fig 1. Case 1. Computed tomography angiography (CTA)
image demonstrates a ﬁstula between the right autoge-
nous vein reconstruction and the right ureter with a
double J stent in situ.
Fig 2. Case 1. Computed tomography angiography (CTA)
maximum intensity projection reconstruction shows an
overview of the aortouni-iliac device with Dacron femo-
rofemoral crossover bypass.
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dilation had grown from 39mm to 77mm (Fig 4). In July 2014, an
endovascular repair using an aortouni-iliac device (Endurant)
was performed on the left side, an occluder device was placed in
the right external iliac artery, and the right leg circulation was
restored by performing an 8-mm rifampicin-soaked Dacron
femorofemoral crossover bypass (Fig 5). Before the operation,
the patient showed no signs of infection; there was no fever, no
increased infection parameters in the laboratory tests
(C-reactive protein, 4.5 mg/L; leukocyte count, 5.66  109/L; and
erythrocyte sedimentation rate, 9 mm/h), and no signs of
infection on CTA. After surgery, the patient recovered well and
was discharged from the hospital with no further complications.
Three years later, the maximum diameter of the NAIS vein
reconstruction is 32 mm. Furthermore, there is good patency of
the stent and femorofemoral crossover bypass, and no endoleak
was observed.DISCUSSION
Performing an in situ NAIS reconstruction using autolo-
gous veins can be a good option for treatment of an
infected aortic graft. Vein graft reconstruction has several
advantages, including a lower rate of reinfection
compared with in situ replacement with a synthetic graft
or cryopreserved allograft.3,6 In addition, long-term
patency with NAIS vein reconstruction is superior to
extra-anatomic bypass.3,8-10 Only a few studies have
examined the long-term outcome of vein reconstruc-
tion.3,5-7 The most common postoperative complication
was stenosis.7 No postoperative dilation was reported
by Ali et al3 (including 187 NAIS reconstructions),
Daenens et al5 (including 49 NAIS reconstructions), or
Gibbons et al6 (including 27 NAIS reconstructions). Only
Ehsan and Gibbons7 diagnosed a false aneurysm in a
subset of patients (4 of 48) after NAIS vein reconstruction.In our second case, the cause of the dilation is unclear.
Perhaps it is due to the quality of the veins used or
progressive arterial disease. Infection was deemed
unlikely because of the absence of fever, increased infec-
tion parameters in the laboratory tests, or signs of infec-
tion on preoperative CTA.
A ﬁstula between the ureter and autogenous vein
reconstruction, as described in the ﬁrst case, was not
reported in the previously mentioned studies.3,5-7 The ﬁs-
tula was presumably caused by iatrogenic ureteral injury
at the NAIS vein reconstruction and subsequent poor
healing due to the presence of local infection. Use of
preoperative ureteral stents might have prevented iatro-
genic ureteral injury during the NAIS vein reconstruction
and therefore also the ﬁstula. Seven weeks after the NAIS
vein reconstruction and 1 week after removal of the dou-
ble J catheter, the ﬁstula was diagnosed, so presumably
the ureter defect had not healed yet. A few studies
reported a positive outcome using endovascular repair
to treat a primary arterioureteral ﬁstula.11-14
Fig 3. Case 2. Computed tomography angiography (CTA) maximum intensity projection reconstruction (from
June 3, 2012) 4 weeks after surgery, in situ neoaortoiliac system (NAIS) autogenous vein reconstruction using
both femoral veins. On the left side, a double system in the femoral vein was accepted. A, Coronal view. B,
Sagittal view.
Fig 4. Case 2. Computed tomography angiography (CTA)
maximum intensity projection reconstruction (from June
11, 2014) demonstrates an aneurysm of 77 mm 2 years after
neoaortoiliac system (NAIS) vein reconstruction. In the
meantime (January 2014), the patient underwent a lapa-
roscopic nephrectomy (left) because of an afunctional
kidney due to recurrent infections.
Fig 5. Case 2. Computed tomography angiography (CTA)
maximum intensity projection reconstruction shows an
overview of the aortouni-iliac device with Dacron femo-
rofemoral crossover bypass. The aneurysm had resolved.
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December 2018An endovascular repair was chosen for both patients
because of the high chance of having to deal with a “hos-
tile abdomen,” which could make open repair difﬁcult
and high risk. In the ﬁrst case, a short graft to control
the bleeding was considered but not chosen because
we wanted a deﬁnitive treatment. If a short graft became
infected, open surgery would probably be needed to
solve the problem. We considered the patient unﬁt for
this type of abdominal surgery. Also, a left aortouni-iliac
device and metal alloy plug placement of the right side
was considered but did not have our preference because
we wanted to seal the defect (ﬁstula). If the ﬁstula was
not sealed, there was still an open connection between
the urinary tract and vascular systems. Hence, there
was more potential risk for development of a complica-
tion or infection (urinoma, thrombus or embolus,
infected hematoma, abscess). The risk of stent infection
in the ﬁrst patient was accepted and reduced by anti-
biotic cover preoperatively and postoperatively. Both
patients tolerated the procedure well, without
complications.
CONCLUSIONS
By presenting these two cases, we wish to emphasize
that an endovascular strategy can be a good alternative
for a high-risk open repair in patients with complications
after NAIS vein reconstruction.REFERENCES
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